Recruiting
Phase 2

Gemcitabine, Docetaxel, Toripalimab

Sponsor:

Stanford University

Code:

NCT06592599

Conditions

Nasopharyngeal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Toripalimab

Concurrent Chemoradiation and Adjuvant treatment following Chemoradiation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-10. This information was provided to ClinicalTrials.gov by Stanford University on 2025-02-24.